Thierry Bussière

8.6k total citations · 2 hit papers
29 papers, 4.1k citations indexed

About

Thierry Bussière is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Thierry Bussière has authored 29 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 10 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Thierry Bussière's work include Alzheimer's disease research and treatments (23 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Dementia and Cognitive Impairment Research (6 papers). Thierry Bussière is often cited by papers focused on Alzheimer's disease research and treatments (23 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Dementia and Cognitive Impairment Research (6 papers). Thierry Bussière collaborates with scholars based in United States, France and Switzerland. Thierry Bussière's co-authors include André Delacourte, Luc Buée, Valérie Buée‐Scherrer, Patrick R. Hof, Daniel P. Perl, Pantéleimon Giannakopoulos, John H. Morrison, Constantin Bouras, Garry E. Gold and François R. Herrmann and has published in prestigious journals such as Journal of Neuroscience, Brain and Neurology.

In The Last Decade

Thierry Bussière

27 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

2000 1.6k citations Luc Buée, Thierry Bussière et al. Brain Research Reviews profile →
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

2003 832 citations Pantéleimon Giannakopoulos, François R. Herrmann et al. profile →

Peers

Countries citing papers authored by Thierry Bussière

Since Specialization

Citations

This map shows the geographic impact of Thierry Bussière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Bussière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Bussière more than expected).

Fields of papers citing papers by Thierry Bussière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Bussière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Bussière. The network helps show where Thierry Bussière may publish in the future.

Co-authorship network of co-authors of Thierry Bussière

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Bussière. A scholar is included among the top collaborators of Thierry Bussière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Bussière. Thierry Bussière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies 2025 ·Molecular Neurodegeneration ·Heike Hering, Thierry Bussière, Chia‐Chen Liu, Kelly E. Glajch, Andreas Weihofen, Jane L. Grogan, (unknown)	0
2	Tau, synapse loss and gliosis progress in an Alzheimer’s mouse model after amyloid-β immunotherapy 2024 ·Brain ·(unknown), (unknown), (unknown), (unknown), (unknown), Luc Buée, Lori B. Chibnik, Thierry Bussière, Bradley T. Hyman	2
3	Alzheimer disease neuropathology in a patient previously treated with aducanumab 2022 ·Acta Neuropathologica ·Edward D. Plowey, Thierry Bussière, Raj Rajagovindan, (unknown), Stefan Hamann, Christian von Hehn, Carmen Castrillo‐Viguera, Alfred Sandrock, Samantha Budd Haeberlein, Christopher H. van Dyck, Anita Hüttner	28
4	Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies 2020 ·Nature Structural & Molecular Biology ·Sara Linse, Tom Scheidt, Katja Bernfur, Michele Vendruscolo, Christopher M. Dobson, Samuel I. A. Cohen, (unknown), Martin Lundqvist, Fang Qian, Tiernan T. O’Malley, Thierry Bussière, Paul H. Weinreb, Catherine K. Xu, Georg Meisl, Sean R. A. Devenish, Tuomas P. J. Knowles, Oskar Hansson	154
5	Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β 2018 ·Scientific Reports ·Joseph W. Arndt, Fang Qian, Benjamin Smith, Chao Quan, Krishna Praneeth Kilambi, Martin Bush, Thomas Walz, R. Blake Pepinsky, Thierry Bussière, Stefan Hamann, Thomas O. Cameron, Paul H. Weinreb	245
6	Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice 2016 ·Journal of Neuroscience ·Ksenia V. Kastanenka, Thierry Bussière, (unknown), Fang Qian, Paul H. Weinreb, (unknown), Brian J. Bacskai	82
7	BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease 2015 ·Neuropharmacology ·Robert H. Scannevin, Sowmya Chollate, Melanie S. Brennan, (unknown), Hairuo Peng, Lin Xu, (unknown), Thierry Bussière, (unknown), Tina Talreja, Zhili Xin, Robert W. Dunstan, (unknown), Ellen Rohde, Anthone W. Dunah, Joy Wang, G. Kumaravel, Arthur G. Taveras, H. Moore Arnold, Kenneth J. Rhodes	11
8	P2–411: Amelioration of calcium dyshomeostasis by immunotherapy with BIIB037 in Tg2576 mice 2013 ·Alzheimer s & Dementia ·Ksenia V. Kastanenka, Thierry Bussière, (unknown), Fang Qian, (unknown), Brian J. Bacskai	0
9	Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive Aβ Immunotherapy on Their Clearance 2004 ·American Journal Of Pathology ·Thierry Bussière, Frédérique Bard, Robin Barbour, (unknown), Terry Guido, Karen Khan, Dale Schenk, Dora Games, Peter Seubert, Manuel Buttini	130
10	Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies 2004 ·Neuropathology and Applied Neurobiology ·Claude‐Alain Maurage, Thierry Bussière, Nicolas Sergeant, (unknown), Dominique Figarella‐Branger, M M Ruchoux, J F Pellissier, André Delacourte	25
11	Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins—a role in nuclear localization 2003 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Tony Lefebvre, Stéphanie Ferreira, (unknown), Thierry Bussière, (unknown), André Delacourte, Jean‐Claude Michalski, Marie‐Laure Caillet‐Boudin	174
12	Progressive degeneration of nonphosphorylated neurofilament protein‐enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9 2003 ·The Journal of Comparative Neurology ·Thierry Bussière, Pantéleimon Giannakopoulos, Constantin Bouras, Daniel P. Perl, John H. Morrison, Patrick R. Hof	142
13	Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease 2002 ·Neuroscience ·Thierry Bussière, (unknown), Neda Sadeghi, Bridget Wicinski, (unknown), Constantin Bouras, Pantéleimon Giannakopoulos, Nikolaos K. Robakis, John H. Morrison, Daniel P. Perl, Patrick R. Hof	91
14	Clinical Validity of Aß-Protein Deposition Staging in Brain Aging and Alzheimer Disease 2001 ·Journal of Neuropathology & Experimental Neurology ·Garry E. Gold, Enikò Kövari, (unknown), François R. Herrmann, Alessandra Canuto, Thierry Bussière, Patrick R. Hof, Constantin Bouras, Pantéleimon Giannakopoulos	52
15	Practical approaches to stereology in the setting of aging- and disease-related brain banks 2000 ·Journal of Chemical Neuroanatomy ·Daniel P. Perl, Paul F. Good, Thierry Bussière, John H. Morrison, Joseph Erwin, Patrick R. Hof	51
16	Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work. breakdown → 2000 ·Brain Research Reviews ·Luc Buée, Thierry Bussière, Valérie Buée‐Scherrer, André Delacourte, (unknown)	1578
17	Pathological Tau Phenotypes: The Weight of Mutations, Polymorphisms, and Differential Neuronal Vulnerabilities 2000 ·Annals of the New York Academy of Sciences ·Christel Vanbesien-Mailliot, Thierry Bussière, Malika Hamdane, Nicolas Sergeant, (unknown), André Delacourte, Luc Buée	23
18	Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration 1999 ·Acta Neuropathologica ·Thierry Bussière, Patrick R. Hof, Christel Vanbesien-Mailliot, Christopher Brown, Marie‐Laure Caillet‐Boudin, Daniel P. Perl, Luc Buée, André Delacourte	89
19	Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation 1998 ·Neuroscience Letters ·Christel Vanbesien-Mailliot, Thierry Bussière, Marie‐Laure Caillet‐Boudin, André Delacourte, Luc Buée	30
20	Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins 1995 ·Neuroreport ·Nicolas Sergeant, Thierry Bussière, Patrick Vermersch, Julien Lejeune, A. Delacourte	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact